Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GNMSF) Non Operating Income (2024 - 2025)

Historic Non Operating Income for Genmab A (GNMSF) over the last 2 years, with Q3 2025 value amounting to $23.0 million.

  • Genmab A's Non Operating Income rose 14035.09% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.0 million, marking a year-over-year change of. This contributed to the annual value of $354.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Genmab A reported Non Operating Income of $23.0 million as of Q3 2025, which was up 14035.09% from $63.0 million recorded in Q2 2025.
  • In the past 5 years, Genmab A's Non Operating Income registered a high of $207.0 million during Q4 2024, and its lowest value of -$57.0 million during Q3 2024.